ARMEN GARO H purchased $945 of PTIX
ARMEN GARO H (EXEC. CHAIR & PRINCIPAL OFF) purchased 2,700 shares of Protagenic Therapeutics, Inc.\new (PTIX) at $0.35 on 2026-08-19.
How this was made
The 30-second read
Why it matters
The disclosed purchase adds a minor data point to PTIX's insider activity profile.
Market read
Routine insider purchase with limited trading relevance.
What to watch
Potential upcoming clinical data releases could make the insider's confidence more meaningful.
Background
Form 4 filings disclose insider transactions; PTIX is a clinical-stage biotech listed on Nasdaq.
Ticker impact
Exec Chair Armen Garo H purchased 2,700 shares of PTIX at $0.35 each, total $945, filing a Form 4 on 2026-08-20.
Minimal short-term price movement expected.
The purchase is under $1M and represents a tiny fraction of float, unlikely to move the stock materially.
Market effects
None significant; biotech sector not materially affected by a micro insider trade.
No regional impact.
Negligible.
Counterpoint
The insider purchase could be a subtle signal of upcoming positive news, but size is too small to be reliable.
Key entities
- ExecutiveArmen Garo H
Executive Chair & Principal Officer of PTIX.
- CompanyProtagenic Therapeutics, Inc.
Biotech firm developing therapies for rare diseases.